Home/finance/Form 4 Senti Biosciences Holdings Inc: Kanya Rajangam (Pres. & Chief Med. & Dev. Off.) For: 21 October - Investing.com Australia

Form 4 Senti Biosciences Holdings Inc: Kanya Rajangam (Pres. & Chief Med. & Dev. Off.) For: 21 October - Investing.com Australia

10/24/2026, 7:36:51 AM

EXECUTIVE SUMMARY

Form 4 Senti Biosciences Holdings Inc: Kanya Rajangam (Pres. & Chief Med. & Dev. Off.) For: 21 October Investing.com Australia

Form 4 Senti Biosciences Holdings Inc: Kanya Rajangam (Pres. & Chief Med. & Dev. Off.) For: 21 October  Investing.com Australia

Published originally on Google News - Stock Market

finance10 minutes ago

Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial

Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial....

Investing.com

finance11 minutes ago

Fuel prices on Saturday following decision of Automatic Pricing Committee for Petroleum Products Egypt Independent

Google News - Oil

finance11 minutes ago

Form 4 DevvStream Legacy Corp.: Helena Global Investment Opportunities 1 Ltd. (10% Owner) For: 16 October Investing.com Australia

Google News - Stock Market

finance11 minutes ago

Form 144 NASDAQ For: 24 October By Investing.com Investing.com Australia

Google News - Stock Market

Multikhabar App

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!